Does Nys Medicaid Cover Wegovy

Nys Medicaid, a health insurance program in New York State, may cover Wegovy, a prescription drug used for weight management in certain individuals. Coverage depends on various factors such as your eligibility for Medicaid, your doctor’s assessment of your condition, and the specific criteria set by the Medicaid program. To determine if you qualify for coverage, you can contact your local Medicaid office, visit their website, or speak with your healthcare provider for more information. They can assist you in understanding the coverage details and guide you through the application process.

Wegovy Coverage Under New York Medicaid

NYS Medicaid typically offers comprehensive coverage for Wegovy, a medication used in weight management, subject to specific guidelines and eligibility criteria. This article provides a detailed overview of the coverage, including eligibility factors, coverage requirements, and the application process.

Eligibility Criteria for Wegovy Coverage

To qualify for Wegovy coverage under NYS Medicaid, individuals must meet several eligibility requirements:

  • Age: Individuals must be 18 years or older.
  • New York State Residency: Applicants must have a permanent residential address within New York State.
  • Income Guidelines: Household income must fall within specified limits set by NYS Medicaid.
  • Citizenship Status: U.S. citizenship or lawful resident status is necessary.
  • Disability or Medical Condition: Individuals must meet specific disability criteria or have a qualifying medical condition, such as obesity with associated health risks.

Coverage Requirements for Wegovy

NYS Medicaid coverage for Wegovy is subject to the following requirements:

  • Prior Authorization: Prior authorization from Medicaid is required before Wegovy can be prescribed and dispensed.
  • Step Therapy: Individuals may be required to try and fail alternative, less expensive weight loss medications before Wegovy is approved.
  • Quantity Limits: NYS Medicaid may impose limits on the number of doses or refills authorized for each prescription.
  • Pharmacy Restrictions: Wegovy may only be dispensed through specific pharmacies or healthcare providers authorized by NYS Medicaid.

Application Process for Wegovy Coverage

Individuals seeking Wegovy coverage under NYS Medicaid can apply through the following channels:

  1. Online Application: Visit the official NYS Medicaid website and fill out an online application form.
  2. In-Person Application: Visit a local Medicaid office and submit a paper application form.
  3. Mail-In Application: Request a paper application form by contacting the NYS Medicaid office and mail it after completing it.

Additionally, individuals may contact the NYS Medicaid helpline or visit the official website for more information on eligibility criteria, coverage details, and the application process.

Summary of Wegovy Coverage Under NYS Medicaid
Factor Requirement
Age 18 years or older
NYS Residency Permanent residential address in New York State
Income Guidelines Must fall within specified limits set by NYS Medicaid
Citizenship Status U.S. citizenship or lawful resident status
Disability or Medical Condition Must meet disability criteria or have a qualifying medical condition
Prior Authorization Required before Wegovy can be prescribed and dispensed
Step Therapy May be required to try alternative weight loss medications first
Quantity Limits May be imposed on the number of doses or refills authorized
Pharmacy Restrictions May only be dispensed through authorized pharmacies or healthcare providers
Application Process Online, in-person, or mail-in application

Individuals who meet the eligibility criteria and fulfill the coverage requirements can access Wegovy as part of their NYS Medicaid benefits. It is recommended to consult with a healthcare provider and the NYS Medicaid office for personalized guidance and assistance with the application process.

Prior Authorization Requirements

In order to receive Wegovy coverage through NYS Medicaid, certain prior authorization requirements must be met. These requirements include:

  • The patient must have a diagnosis of obesity (BMI ≥ 30 kg/m2) or overweight (BMI ≥ 27 kg/m2) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or sleep apnea.
  • The patient must have tried and failed to lose weight through lifestyle modifications such as diet and exercise.
  • The patient must not have any contraindications to Wegovy use, such as a history of pancreatitis or medullary thyroid cancer.

To obtain prior authorization, the patient’s healthcare provider must submit a prior authorization request to the NYS Medicaid Managed Care Organization (MCO) that the patient is enrolled in. The request must include the following information:

  • The patient’s name, date of birth, and Medicaid ID number.
  • The patient’s diagnosis of obesity or overweight with a weight-related comorbidity.
  • The patient’s history of weight loss attempts through lifestyle modifications.
  • The patient’s current weight and height.
  • Any contraindications to Wegovy use.

The MCO will review the prior authorization request and make a decision within 10 business days. If the request is approved, the patient will be able to receive Wegovy coverage through NYS Medicaid.

Table 1: Prior Authorization Requirements for Wegovy Coverage Through NYS Medicaid
Requirement Description
Diagnosis of obesity or overweight with a weight-related comorbidity Patient must have a BMI ≥ 30 kg/m2 or a BMI ≥ 27 kg/m2 with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or sleep apnea.
History of weight loss attempts through lifestyle modifications Patient must have tried and failed to lose weight through lifestyle modifications such as diet and exercise.
No contraindications to Wegovy use Patient must not have any contraindications to Wegovy use, such as a history of pancreatitis or medullary thyroid cancer.
Prior authorization request submitted to NYS Medicaid MCO Patient’s healthcare provider must submit a prior authorization request to the NYS Medicaid MCO that the patient is enrolled in.
MCO review and decision MCO will review the prior authorization request and make a decision within 10 business days.
Coverage approval If the request is approved, the patient will be able to receive Wegovy coverage through NYS Medicaid.

NYS Medicaid Coverage for Wegovy

Wegovy (semaglutide) is a prescription drug used to treat weight management in adults with obesity or who are overweight. It is a once-weekly injectable that helps regulate appetite and reduce body weight. Many are asking whether NYS Medicaid covers Wegovy. The answer is yes, but coverage and reimbursement rates vary depending on individual circumstances.

Reimbursement Rates

NYS Medicaid reimburses Wegovy at a rate based on the Average Wholesale Price (AWP) of the drug. The AWP is the manufacturer’s suggested price for the drug, and it is used as a benchmark for determining reimbursement rates. Currently, the AWP for Wegovy is $1,349.06 per 2.4mg dose. NYS Medicaid reimburses 60% of the AWP, which means that the state will pay $809.44 for each 2.4mg dose of Wegovy.

Coverage Duration

NYS Medicaid covers Wegovy for up to 12 months. This means that the state will pay for up to 12 doses of the drug. After 12 months, patients will need to reapply for coverage.

Who is Eligible for Coverage?

To be eligible for NYS Medicaid coverage of Wegovy, patients must meet the following criteria:

  • Be a resident of New York State
  • Be enrolled in Medicaid
  • Have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with a weight-related health condition, such as high blood pressure, type 2 diabetes, or heart disease.

Additionally, patients must also meet certain income and asset limits to be eligible for Medicaid coverage.

How to Apply for Coverage

To apply for NYS Medicaid coverage of Wegovy, patients can either:

  • Apply online through the NYS Medicaid website
  • Call the NYS Medicaid Customer Service Center at 1-855-355-5777
  • Visit a local Medicaid office

Patients will need to provide documentation of their income, assets, and medical history when they apply.

Once a patient’s application is approved, they will receive a Medicaid ID card. This card can be used to pay for Wegovy at participating pharmacies.

Coverage Details
Reimbursement Rate 60% of the Average Wholesale Price (AWP)
Coverage Duration Up to 12 months
Eligibility Criteria – Resident of New York State
– Enrolled in Medicaid
– BMI of 30 or higher, or BMI of 27 or higher with a weight-related health condition
– Meet income and asset limits
How to Apply – Online through the NYS Medicaid website
– Call the NYS Medicaid Customer Service Center
– Visit a local Medicaid office

Alternatives to Wegovy

If your claim for Wegovy is denied, there are a few alternatives you can consider:

  • Ozempic (semaglutide): Ozempic is a once-weekly injectable medication that is FDA-approved for the treatment of type 2 diabetes. It is also sometimes used off-label for weight loss. Ozempic is typically covered by Medicaid, but you may need to get prior authorization from your doctor.
  • Mounjaro (tirzepatide): Mounjaro is a once-weekly injectable medication that is FDA-approved for the treatment of type 2 diabetes. It is also sometimes used off-label for weight loss. Mounjaro is typically covered by Medicaid, but you may need to get prior authorization from your doctor.
  • Saxenda (liraglutide): Saxenda is a once-daily injectable medication that is FDA-approved for the treatment of obesity. It is typically covered by Medicaid, but you may need to get prior authorization from your doctor.
  • Qsymia (phentermine and topiramate): Qsymia is a combination of two medications, phentermine and topiramate, that is FDA-approved for the treatment of obesity. It is typically covered by Medicaid, but you may need to get prior authorization from your doctor.

Appealing a Denied Claim

If your claim for Wegovy is denied, you have the right to appeal the decision. The appeals process can be complex, so it is important to follow the instructions on your denial letter carefully. In general, the appeals process involves the following steps:

  1. Request a reconsideration: The first step is to request a reconsideration of the decision. This means that you will submit additional information to the insurance company to support your claim. You should include any new medical information, such as a letter from your doctor, as well as any information about your financial situation.
  2. Request an independent review: If your reconsideration request is denied, you can request an independent review. This means that your claim will be reviewed by an independent third party. The independent reviewer will make a decision based on the evidence that you submit.
  3. File a complaint with the state insurance department: If you are still not satisfied with the outcome of your appeal, you can file a complaint with the state insurance department. The insurance department will investigate your complaint and may take action against the insurance company if they find that they have violated any laws or regulations.

Table of Weight Loss Medications Covered by NYS Medicaid

Medication Dosage Approval
Wegovy (semaglutide) 2.4 mg once weekly Yes
Ozempic (semaglutide) 0.5 mg, 1 mg, or 2 mg once weekly Yes
Mounjaro (tirzepatide) 2.5 mg, 5 mg, 7.5 mg, 10 mg, or 15 mg once weekly Yes
Saxenda (liraglutide) 3 mg once daily Yes
Qsymia (phentermine and topiramate) 3.75 mg/28 mg once daily or 7.5 mg/46 mg once daily Yes

Hey there, folks! Thanks for taking the time to read about whether New York Medicaid covers Wegovy. We really appreciate your interest in the topic. I hope you found some valuable information here. Remember, folks, knowledge is power, and staying informed about healthcare options can make a big difference. If you have any more questions or need more info, don’t hesitate to drop by again. We’ll be here to help you navigate the world of Medicaid coverage and keep you updated on the latest developments, making sure you’re always in the know. See you next time, folks!